Article

ACC 2011 Interview on Cost Analysis Substituting Dabigatran for Warfarin

Dr. Julie Atay discusses her poster at ACC 2011 on "Cost Analysis of Substituting Dabigatran for Warfarin in an Anticoagulant Management Program."

Related Videos
Screenshot of an interview with Evangelia Vlachou, MD
Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health
Screenshot of an interview with Barry Goy, MD
Gladys Antelo Allen
Dr Michael Bernstein
Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine
Debra Patt, MD, PhD, MBA, MPH
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Mikkael Sekeres, MD
Kim Newcomer, director of volunteers, Colorectal Cancer Alliance
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo